Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul;134(1):91-101.
doi: 10.1097/AOG.0000000000003331.

A Qualitative Study of the Contraceptive Effect on Women's Sexual Experiences: Beyond Hormonal Effects

Affiliations

A Qualitative Study of the Contraceptive Effect on Women's Sexual Experiences: Beyond Hormonal Effects

Connie F Lu et al. Obstet Gynecol. 2019 Jul.

Abstract

Objective: To elucidate the effects of the intravaginal ring, oral contraceptive pill (OCP), and spermicide plus condom on women's sexual experiences through an in-depth understanding of the physical characteristics of these contraceptive methods.

Methods: We conducted qualitative in-depth interviews with women (aged 18-45 years) who used up to three contraceptive methods (intravaginal ring, OCP, and spermicide plus condom). Women completed in-depth interviews after each 3-month use period. We used a summarized matrix framework and thematic content analysis to explore how each method affected participants' sexual experiences.

Results: Sixteen women completed interviews, yielding 33 transcripts. Women reported physical effects on their sexual experiences while using the intravaginal ring and spermicide plus condom. The OCP was often discussed as lacking these physical effects. Discussion themes included product administration (eg, navigating intravaginal ring removal) and physical product awareness (eg, spermicide as a lubricant). From these experiences, women often altered and individualized their use and subsequent opinions of the contraceptive method.

Conclusion: The range of contraceptive effects on women's sexual experiences shape their use and opinions of the product, leading to either increased motivation and consistent use or poor adherence and discontinuation. Awareness of these individualized experiences can help providers better understand and guide their patients towards successful contraceptive use.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Data collection and descriptions of surveys and interviews.
Figure 2.
Figure 2.
Flow diagram of participant selection and study. BMI, body mass index. *Unrelated.
Figure 3.
Figure 3.
Representation of overarching themes as organized for each contraceptive method. Illustrative quotes are attributed to each participant by their age and contraceptive method used before the study: [A] and [B] are used to distinguish individuals with the same characteristics and correspond accordingly to their quotes in the text. OCP, oral contraceptive pill, y, years.
Figure 4.
Figure 4.
Flow diagram describing the range of reasons behind participants’ decisions and timing surrounding intravaginal ring removal (n=12).

Similar articles

Cited by

References

    1. Higgins JA and Hirsch JS, The Pleasure Deficit: Revisiting the “Sexuality Connection” in Reproductive Health. Perspectives on Sexual and Reproductive Health, 2007. 39(4): p. 240–247. - PubMed
    1. Higgins JA and Hirsch JS, Pleasure, Power, and Inequality: Incorporating Sexuality Into Research on Contraceptive Use. American Journal of Public Health, 2008. 98(10): p. 1803–1813. - PMC - PubMed
    1. Sanders SA, et al., A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception, 2001. 64(1): p. 51–8. - PubMed
    1. Smith NK, Jozkowski KN, and Sanders SA, Hormonal Contraception and Female Pain, Orgasm and Sexual Pleasure. The Journal of Sexual Medicine, 2014. 11(2): p. 462–470. - PubMed
    1. Caruso S, et al., Conventional vs. extended-cycle oral contraceptives on the quality of sexual life: comparison between two regimens containing 3 mg drospirenone and 20 microg ethinyl estradiol. J Sex Med, 2011. 8(5): p. 1478–85. - PubMed

Publication types